New clinical trial results provide evidence that high-dose immunosuppressive therapy followed by transplantation of a person’s own blood-forming Stem Cells can induce sustained remission of relapsing-remitting Multiple Sclerosis (MS), an autoimmune disease in which the immune system attacks the central nervous system.